ArticleBMC cancer2025

Tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2 positive breast cancer (TUTOR): Study protocol for a multicenter phase 1 clinical trial.

Zouina Sarfraz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.